
Loading, please wait...

Loading, please wait...

The preparation for a colonoscopy often involves intensive bowel cleansing and prolonged fasting. While clinicians commonly monitor adults, new research highlights a significant risk of pediatric bowel preparation hypoglycemia. Specifically, a retrospective study at the Children’s Hospital of Philadelphia analyzed over 5,000 cases to evaluate this metabolic concern. Consequently, the findings suggest that clinicians must remain vigilant regarding blood glucose levels in younger patients before endoscopic procedures.
The study evaluated children and young adults aged 5 months to 27 years. Moreover, researchers discovered that approximately 8% of these patients experienced hypoglycemia before their colonoscopy. In addition, 3% faced moderate hypoglycemia, while 1% suffered from severe drops in blood sugar. Furthermore, the analysis identified specific clinical variables that correlate with a higher risk. Specifically, younger patients and those in lower weight percentiles were significantly more likely to develop hypoglycemia across all severity thresholds.
Therefore, clinicians should prioritize monitoring for these vulnerable groups. Since fasting hypoglycemia can lead to complications during anesthesia, pre-procedure point-of-care glucose testing remains essential. Additionally, medical teams might need to adjust preparation protocols for infants and underweight children to ensure safety. However, further studies are needed to establish standardized glucose management guidelines for this population.
Children have lower glycogen stores and a higher metabolic rate than adults, making them more susceptible to fasting-induced glucose drops during the intensive preparation phase.
The research indicates that younger age and lower weight percentiles are the most significant predictors of hypoglycemia during the bowel preparation process.
Clinicians should implement point-of-care glucose testing before the procedure and consider adjusting fasting protocols for high-risk patients, such as infants or those with low body mass.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare providers with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Hum SW et al. Increased risk of hypoglycemia in children and young adults after undergoing bowel preparation for colonoscopy. Am J Gastroenterol. 2026 May 26. doi: 10.14309/ajg.0000000000004065. PMID: 42189577.
Sahn B et al. Safety of a 1-day polyethylene glycol 3350 bowel preparation for colonoscopy in children. J Pediatr Gastroenterol Nutr. 2016;63(1):19-24. doi: 10.1097/MPG.0000000000001072.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study of 5,129 pediatric colonoscopies found that 8% of patients develop hypoglycemia after bowel preparation, especially younger and underweight children...
3 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today